Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

Although the revenue and EPS for Vertex (VERX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street ...

Vertex Pharmaceuticals (Nasdaq: NASDAQ:VRTX) and Ono Pharmaceutical (OTCMKTS: OTCPK:OPHLY) have announced an exclusive collaboration, for the development and commercialization of Vertex's ...

Vertex Pharmaceuticals (Nasdaq: VRTX) and Ono Pharmaceutical (OTCMKTS: OPHLY) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept in Japan ...

For the full year, analysts expect VRTX to report EPS of $15.67, up significantly from a loss of $1.35 per share in fiscal 2024. Its EPS is expected to further grow 12.4% year-over-year to $17.61 ...